APCO WORLDWIDE LLC

Lobbying for HIKMA PHARMACEUTICALS USA INC. · Pharmaceutical manufacturer

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Jul 15, 2025

Lobbying activity 2

Health Issues

Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues

Trade (domestic/foreign)

Trade policies impacting domestic generic pharmaceutical manufacturing

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.